At this time, posts about Genexine are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 14,000 shares today. Genexine is known as a specialized company in biopharmaceutical development.

As of 11:30 AM on the 1st, Genexine's stock price is 74,700 KRW, down 0.53% from the previous day, with a trading volume of 514,790 shares, which is 116.76% of the 5-day average trading volume.

In addition to Genexine, posts by investors are also surging for Dongguk S&C (100130), Antrogen (065660), and Korea Industries (002140).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing